Mark Stanley Berger Genprex, Inc. (GNPX) insider trading activity

Mark Stanley Berger is Chief Medical Officer of Genprex, Inc.. Currently has a direct ownership of 22,471 shares of GNPX, which is worth approximately $8,538. The most recent transaction as insider was on Feb 18, 2025, when has been sold 585 shares (Common Stock) at a price of $0.41 per share, resulting in proceeds of $239. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.5K

367.56% 3M change

367.56% 12M change

Total Value Held $8,538

Mark Stanley Berger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 18 2025	SELL Payment of exercise price or tax liability	$239 $0.41 p/Share	585 Reduced 2.54%	22,471 Common Stock
Dec 05 2024	BUY Grant, award, or other acquisition	-	18,250 Added 44.18%	23,056 Common Stock
Feb 18 2024	SELL Payment of exercise price or tax liability	$5,803 $4.4 p/Share	1,319 Reduced 21.53%	4,806 Common Stock
Feb 18 2023	BUY Grant, award, or other acquisition	-	245,000 Added 50.0%	245,000 Common Stock

Also insider at

ATNM

Actinium Pharmaceuticals, Inc. Healthcare

Chief Medical Officer

MSB